LENZ Therapeutics, Inc. (LENZ) — Stock Score Summary

LENZ Therapeutics, Inc. (LENZ) has a MoatMap StockRank of 7/100 based on Quality (37/100), Value (42/100), and Momentum (8/100) factor scores. The current signal is STRONG SELL. LENZ Therapeutics, Inc. is a small-cap healthcare company whose operations are not directly impacted by or benefiting from the identified macro themes. It lacks the characteristics of a quality compounder with an unpriced macro tailwind.

LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for presbyopia, an age-related loss of near vision. It targets a large, underserved patient population with an innovative, non-surgical solution, aiming to offer a more convenient and effective treatment option. LENZ is a specialty ophthalmology biopharma focused on commercializing a potentially first-in-class product for a widespread vision condition.

Key Financial Metrics

Price$7.55
Market Cap$237M
P/E (Forward)-1.92
Price/Book0.73
Return on Equity-49.7%
Return on Invested Capital-32.0%
Debt/Equity0.27
Gross Margin92.9%
Operating Margin-2321.7%
Free Cash Flow$-49M

LENZ Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is LENZ Therapeutics, Inc.’s (LENZ) StockRank?
MoatMap’s StockRank for LENZ Therapeutics, Inc. (LENZ) is 7/100, with a Strong Sell signal. It is a composite of Quality (37), Value (42), and Momentum (8) factor ranks across MoatMap’s 19,000+ stock universe.
Does LENZ Therapeutics, Inc. have an economic moat?
LENZ Therapeutics, Inc. (LENZ) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is LENZ Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for LENZ Therapeutics, Inc. (LENZ) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is LENZ Therapeutics, Inc. in?
LENZ Therapeutics, Inc. (LENZ) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksLENZ deep dive reportAI ChampionsHow we score stocksSense-check another stock